80岁以上卒中患者3小时内与3-4.5小时溶栓结局比较
基于SITS国际溶栓登记2003-2015年14240例>80岁急性缺血性卒中患者,比较3小时内与3-4.5小时静脉溶栓的结局。3-4.5小时组调整后功能独立率较低、症状性颅内出血较高,死亡率无差异;绝对差异小,不应仅因年龄拒绝后期溶栓。
要点
- >80岁患者3-4.5小时溶栓调整后功能独立率低于3小时内组。
- 3-4.5小时组症状性颅内出血率高于3小时内组。
- 两时间窗死亡率无显著差异,不应仅因年龄拒绝后期溶栓。
核心结论
- >80岁患者3小时后溶栓较3小时内症状性颅内出血稍高,未调整功能结局相似但调整后较差。
- 治疗组间绝对差异小,无其他禁忌时不应仅因年龄拒绝后期时间窗溶栓。
研究设计与样本
- 基于SITS国际卒中溶栓登记2003-2015年的观察性研究。
- 共纳入14240例>80岁急性缺血性卒中接受静脉溶栓≤4.5小时的患者,其中3558例在>3-4.5小时。
- 8658例符合欧洲产品特征摘要(EU SmPC)阿替普酶标准,其中2157例在>3-4.5小时。
主要发现
- 3-4.5小时组与≤3小时组中位年龄均为84岁,女性均占61%。
- 3-4.5小时组与≤3小时组中位NIHSS评分分别为12分与14分。
- 3个月功能独立分别为34%与35%(aOR 0.78,95%CI 0.69-0.89,p<0.001)。
- 死亡率分别为31%与32%(aOR 1.10,95%CI 0.97-1.25,p=0.13)。
- 症状性颅内出血(SICH/SITS)分别为2.7%与1.6%(aOR 1.72,95%CI 1.25-2.35,p=0.001)。
关键数值与推荐
- EU SmPC合规患者中3个月功能独立分别为36%与37%(aOR 0.79,95%CI 0.68-0.92,p=0.002)。
- EU SmPC合规患者中死亡率分别为29%与29.6%(aOR 1.10,95%CI 0.95-1.28,p=0.20)。
- EU SmPC合规患者中SICH/SITS分别为2.7%与1.6%(aOR 1.62,95%CI 1.12-2.34,p=0.01)。
临床怎么用
- >80岁患者后期时间窗溶栓需权衡稍高的症状性颅内出血风险与调整后功能结局稍差。
- 无其他禁忌时不应仅因年龄拒绝3-4.5小时时间窗的静脉溶栓。
局限性
- 为观察性研究,存在组间基线差异(如NIHSS评分不同)和未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine outcomes and risks of IV thrombolysis (IVT) in patients with acute ischemic stroke (AIS) >80 years of age within 3 hours compared to >3 to 4.5 hours recorded in the Safe Implementation of Treatment in Stroke (SITS) International Stroke Thrombolysis Registry. METHODS: A total of 14,240 (year 2003-2015) patients >80 years of age with AIS were treated with IVT ≤4.5 hours of stroke onset (3,558 in >3-4.5 hours). Of these, 8,658 (2,157 in >3-4.5 hours) were treated otherwise according to the European Summary of Product Characteristics (EU SmPC) criteria for alteplase. Outcomes were 3-month functional independence (modified Rankin Scale score 0-2), mortality, and symptomatic intracerebral hemorrhage (SICH)/SITS. Results were compared between the groups treated in >3 to 4.5 and ≤3 hours. RESULTS: Median age was 84 years; 61% were female in both groups. Median NIH Stroke Scale score was 12 vs 14 in the >3- to 4.5- and ≤3-hour group, respectively. Three-month functional independence was 34% vs 35% (adjusted odds ratio [aOR] 0.78, 95% confidence interval [CI] 0.69-0.89, p < 0.001); mortality was 31% vs 32% (aOR 1.10, 95% CI 0.97-1.25, p = 0.13); and SICH/SITS was 2.7% vs 1.6% (aOR 1.72, 95% CI 1.25-2.35, p = 0.001). In EU SmPC-compliant patients, 3-month functional independence was 36 vs 37% (aOR 0.79, 95% CI 0.68-0.92, p = 0.002), mortality was 29% vs 29.6% (aOR 1.10, 95% CI 0.95-1.28, p = 0.20), and SICH/SITS was 2.7% vs 1.6% (aOR 1.62, 95% CI 1.12-2.34, p = 0.01). CONCLUSIONS: In this observational study, unselected patients >80 years of age treated with IVT after 3 hours vs earlier had a slightly higher rate of SICH and similar unadjusted functional outcome but poorer adjusted outcome. The absolute difference between the treatment groups is small, and elderly patients should not be denied IVT in the later time window solely because of age without other contraindications.
引用
- Ahmed N, Lees KR, Ringleb PA, et al. Outcome after stroke thrombolysis in patients >80 years treated within 3 hours vs >3-4.5 hours. Neurology. 2017. PMID: 28887377. doi:10.1212/WNL.0000000000004499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。